159 related articles for article (PubMed ID: 37181717)
1. Effect of mobile health reminders on tuberculosis treatment outcomes in Shanghai, China: A prospective cohort study.
Wu Z; Lu L; Li Y; Chen J; Zhang Z; Ning C; Yuan Z; Pan Q; Shen X; Zhang W
Front Public Health; 2023; 11():923319. PubMed ID: 37181717
[TBL] [Abstract][Full Text] [Related]
2. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Blumberg HM; Marconi VC
Trials; 2020 May; 21(1):383. PubMed ID: 32370774
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial.
Liu X; Lewis JJ; Zhang H; Lu W; Zhang S; Zheng G; Bai L; Li J; Li X; Chen H; Liu M; Chen R; Chi J; Lu J; Huan S; Cheng S; Wang L; Jiang S; Chin DP; Fielding KL
PLoS Med; 2015 Sep; 12(9):e1001876. PubMed ID: 26372470
[TBL] [Abstract][Full Text] [Related]
4. Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patients' treatment adherence via electronic monitors and an app versus usual care in Tibet.
Wei X; Hicks JP; Pasang P; Zhang Z; Haldane V; Liu X; Yin T; Wang L; Shi D; Ge S; Walley J; Upshur R; Hu J
Trials; 2019 May; 20(1):273. PubMed ID: 31097023
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for poor engagement with a smart pillbox adherence intervention among persons on tuberculosis treatment in Ethiopia.
Tadesse AW; Cusinato M; Weldemichael GT; Abdurhman T; Assefa D; Yazew H; Gadissa D; Shiferaw A; Belachew M; Sahile M; van Rest J; Bedru A; Foster N; Jerene D; Fielding KL
BMC Public Health; 2023 Oct; 23(1):2006. PubMed ID: 37838677
[TBL] [Abstract][Full Text] [Related]
6. Implementation Intention and Reminder Effects on Behavior Change in a Mobile Health System: A Predictive Cognitive Model.
Pirolli P; Mohan S; Venkatakrishnan A; Nelson L; Silva M; Springer A
J Med Internet Res; 2017 Nov; 19(11):e397. PubMed ID: 29191800
[TBL] [Abstract][Full Text] [Related]
7. Mobile Health for Tuberculosis Management in South India: Is Video-Based Directly Observed Treatment an Acceptable Alternative?
Kumar AA; De Costa A; Das A; Srinivasa GA; D'Souza G; Rodrigues R
JMIR Mhealth Uhealth; 2019 Apr; 7(4):e11687. PubMed ID: 30942696
[TBL] [Abstract][Full Text] [Related]
8. Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment.
Liu Q; Abba K; Alejandria MM; Sinclair D; Balanag VM; Lansang MA
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006594. PubMed ID: 25403701
[TBL] [Abstract][Full Text] [Related]
9. Implementation and effectiveness of evriMED with short messages service (SMS) reminders and tailored feedback compared to standard care on adherence to treatment among tuberculosis patients in Kilimanjaro, Tanzania: proposal for a cluster randomized controlled trial.
Sumari-de Boer M; Pima FM; Ngowi KM; Chelangwa GM; Mtesha BA; Minja LM; Semvua HH; Mpagama S; Mmbaga BT; Nieuwkerk PT; Aarnoutse RE
Trials; 2019 Jul; 20(1):426. PubMed ID: 31300028
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trial.
Lewis JJ; Liu X; Zhang Z; Thomas BV; Vassall A; Sweeney S; Caihong X; Dongmei H; Xue L; Yongxin G; Huan S; Shiwen J; Fielding KL
Trials; 2018 Jul; 19(1):398. PubMed ID: 30045757
[TBL] [Abstract][Full Text] [Related]
11. Bracelet- and self-directed observational therapy for control of tuberculosis: study protocol for a cluster randomized controlled trial.
Huang R; Ren G; Hu J
Trials; 2017 Jul; 18(1):286. PubMed ID: 28673323
[TBL] [Abstract][Full Text] [Related]
12. Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient-Provider Communication in the START Study.
Hirsch-Moverman Y; Daftary A; Yuengling KA; Saito S; Ntoane M; Frederix K; Maama LB; Howard AA
J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S37-S43. PubMed ID: 27930610
[TBL] [Abstract][Full Text] [Related]
13. Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials.
Ridho A; Alfian SD; van Boven JFM; Levita J; Yalcin EA; Le L; Alffenaar JW; Hak E; Abdulah R; Pradipta IS
J Med Internet Res; 2022 Feb; 24(2):e33062. PubMed ID: 35195534
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among ASCENT trial participants - A multicountry study.
Tadesse AW; Mganga A; Dube TN; Alacapa J; van Kalmthout K; Letta T; Mleoh L; Garfin AMC; Maraba N; Charalambous S; Foster N; Jerene D; Fielding KL
Front Public Health; 2024; 12():1327971. PubMed ID: 38444445
[TBL] [Abstract][Full Text] [Related]
15. Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial.
Liu X; Thompson J; Dong H; Sweeney S; Li X; Yuan Y; Wang X; He W; Thomas B; Xu C; Hu D; Vassall A; Huan S; Zhang H; Jiang S; Fielding K; Zhao Y
Lancet Glob Health; 2023 May; 11(5):e693-e703. PubMed ID: 37061308
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial.
Tadesse AW; Mohammed Z; Foster N; Quaife M; McQuaid CF; Levy J; van Kalmthout K; van Rest J; Jerene D; Abdurhman T; Yazew H; Umeta DG; Assefa D; Weldemichael GT; Bedru A; Letta T; Fielding KL
BMC Infect Dis; 2021 Nov; 21(1):1149. PubMed ID: 34758737
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of a comprehensive package based on electronic medication monitors at improving treatment outcomes among tuberculosis patients in Tibet: a multicentre randomised controlled trial.
Wei X; Hicks JP; Zhang Z; Haldane V; Pasang P; Li L; Yin T; Zhang B; Li Y; Pan Q; Liu X; Walley J; Hu J
Lancet; 2024 Mar; 403(10430):913-923. PubMed ID: 38309280
[TBL] [Abstract][Full Text] [Related]
18. Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers.
Thomas BE; Kumar JV; Periyasamy M; Khandewale AS; Hephzibah Mercy J; Raj EM; Kokila S; Walgude AS; Gaurkhede GR; Kumbhar JD; Ovung S; Paul M; Rajkumar BS; Subbaraman R
J Med Internet Res; 2021 Jun; 23(6):e23294. PubMed ID: 34110300
[TBL] [Abstract][Full Text] [Related]
19. SMS reminders to improve adherence and cure of tuberculosis patients in Cameroon (TB-SMS Cameroon): a randomised controlled trial.
Bediang G; Stoll B; Elia N; Abena JL; Geissbuhler A
BMC Public Health; 2018 May; 18(1):583. PubMed ID: 29720146
[TBL] [Abstract][Full Text] [Related]
20. SMS reminders to improve the tuberculosis cure rate in developing countries (TB-SMS Cameroon): a protocol of a randomised control study.
Bediang G; Stoll B; Elia N; Abena JL; Nolna D; Chastonay P; Geissbuhler A
Trials; 2014 Jan; 15():35. PubMed ID: 24460827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
